GGBR4:BMFBOVESPAGerdau S.A. Pfd Analysis
Data as of 2026-03-11 - not real-time
R$18.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gerdau shares are trading at R$18.80, barely above the calculated support of R$18.30 and well below the resistance of R$22.80, suggesting limited upside in the immediate price range. The RSI of 25 signals that the stock is oversold, while the MACD remains in a bearish configuration, indicating that any short‑term rebound may be fragile. Valuation metrics reinforce the upside narrative: the DCF‑derived fair value implies a potential 30% upside, and the forward P/E of 6.9 contrasts sharply with the trailing P/E of 27, highlighting a market discount to future earnings. Fundamentally, the company delivers modest revenue growth (0.9%) and thin margins, but generates solid operating cash flow and maintains a low price‑to‑book of 0.69, underscoring the value angle. However, the debt‑to‑equity ratio of 28.9 and a payout ratio near 90% raise questions about the sustainability of the 2.12% dividend. Risk‑wise, the stock exhibits high 30‑day volatility and a beta below 1, while operating in the cyclical steel sector, exposing it to commodity price swings and regulatory pressures. The market sentiment is buoyant, as reflected by an “Extreme Greed” reading on the fear‑greed index, but the decreasing volume trend hints at waning buying enthusiasm. Overall, the blend of technical oversold conditions, attractive valuation upside, and cautious fundamentals suggests a nuanced outlook for Gerdau.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicates oversold conditions
- Price is near technical support
- Bearish MACD and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF suggests ~30% upside
- Forward P/E of 6.9 signals strong earnings potential
- Low price‑to‑book ratio and solid cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Cyclical nature of the steel industry
- High leverage (debt‑to‑equity ~29)
- Dividend payout ratio near 90% may limit future sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth0.90%
Profit Margin1.98%
P/E Ratio27.2
ROE2.53%
ROA4.15%
Debt/Equity28.95
P/B Ratio0.7
Op. Cash FlowR$8.0B
Free Cash FlowR$714.7M
Technical Analysis
TrendNeutral
RSI25.5
SupportR$18.30
ResistanceR$22.80
MA 20R$20.73
MA 50R$21.48
MA 200R$18.45
MACDBearish
VolumeDecreasing
Fear & Greed Index77.46
Valuation
Fair ValueR$0.57
Target PriceR$24.57
Upside/Downside30.67%
GradeUndervalued
TypeValue
Dividend Yield2.12%
Risk Assessment
Beta0.72
Volatility30.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.